Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laboni Roy
Observed name:
Roy, Laboni
Institution:
Bose Institute
Observed institution:
Bose Institute
ORCID:
0009-0000-4769-7616
Observed ORCID:
0009-0000-4769-7616
OpenAlex ID:
A5014303680
Targeting Ca2+ signaling: A new arsenal against cancer
2021
·
Suman Panda
, Oishika Chatterjee
, et al.
·
Drug Discovery Today
·
35
Noncoding RNA as an influential epigenetic modulator with promising roles in cancer therapeutics
2023
·
Laboni Roy
, Oishika Chatterjee
, et al.
·
Drug Discovery Today
·
30
Peptide therapeutics in the management of metastatic cancers
2022
·
Debopriya Bose
, Laboni Roy
, et al.
·
RSC Advances
·
26
PDF
Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer
2024
·
Pallabi Sengupta
, Ananya Roy
, et al.
·
International Journal of Biological Macromolecules
·
14
Immune response and possible therapeutics in COVID-19
2021
·
Anindya Dutta
, Ananya Roy
, et al.
·
RSC Advances
·
10
PDF
In Silico‐Designed G‐Quadruplex Targeting Peptide Attenuates VEGF‐A Expression, Preventing Angiogenesis in Cancer Cells
2024
·
Nilanjan Banerjee
, Laboni Roy
, et al.
·
Chemical Biology & Drug Design
·
3
Unraveling the structural aspects of the G-quadruplex in SMO promoter and elucidating its contribution in transcriptional regulation
2023
·
Laboni Roy
, Ananya Roy
, et al.
·
Journal of Biomolecular Structure and Dynamics
·
2
Nucleic Acid Sensors and Logic Gates
2023
·
Debopriya Bose
, Ananya Roy
, et al.
·
Springer eBooks
·
2
Nucleic Acid in Nanotechnology
2023
·
Debopriya Bose
, Laboni Roy
, et al.
·
Springer eBooks
·
1
In Silico designed cell-penetrating anti-cancer peptide specifically inhibits VEGF-A expression
2024
·
Nilanjan Banerjee
, Laboni Roy
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Show more works
View as search
Works count:
11
Citation count:
122
H-index:
5
I10-index:
5
Year
Topic
Type
